Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts $122.25 -2.84 (-2.27%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$122.24 -0.02 (-0.01%) As of 02/4/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Ascendis Pharma A/S Latest Earnings SummaryLatest Earnings DateFeb. 5EstimatedConsensus EPS (Feb. 5) -$1.31 Ascendis Pharma A/S posted Q4 2024 earnings on February 5, 2025, reporting an EPS of $0.00, which beat analysts' consensus estimates of -$1.31 by $1.31. With a trailing EPS of -$8.08, Ascendis Pharma A/S's earnings are expected to grow next year, from ($7.11) to ($4.37) per share. ASND Upcoming EarningsAscendis Pharma A/S's next earnings date is estimated for Wednesday, February 5, 2025, based off prior year's reporting schedules. Get Ascendis Pharma A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ascendis Pharma A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataASND Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ASND Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ascendis Pharma A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.90-$1.86-$1.88Q2 20252-$1.81-$1.25-$1.53Q3 20252-$1.74-$1.01-$1.38Q4 20252-$1.66$1.25-$0.21FY 20258($7.11)($2.87)($4.99) Ascendis Pharma A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/5/2025(Estimated)--$1.31-----9/3/2024Q2 2024-$1.54-$2.05 -$0.51-$2.05$94.74M$38.75M5/2/2024Q1 2024-$1.57-$2.48 -$0.91-$2.48$85.72M$103.11M2/7/2024Q4 2023-$2.15-$1.66+$0.49-$1.66$97.02M$148.62M11/7/2023Q3 2023-$2.63-$3.12 -$0.49-$3.12$52.54M$52.02M9/5/2023Q2 2023-$2.68-$2.35+$0.33-$2.35$41.73M$51.59M4/27/2023Q1 2023-$2.84-$2.12+$0.72-$2.12$24.53M$36.04M2/16/2023Q4 2022-$2.50-$3.78 -$1.28-$3.78$20.31M$23.38M Ascendis Pharma A/S Earnings - Frequently Asked Questions When is Ascendis Pharma A/S's earnings date? Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates. Learn more on ASND's earnings history. Did Ascendis Pharma A/S beat their earnings estimates last quarter? In the previous quarter, Ascendis Pharma A/S (NASDAQ:ASND) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.31) by $1.31. Learn more on analysts' earnings estimate vs. ASND's actual earnings. How much revenue does Ascendis Pharma A/S generate each year? Ascendis Pharma A/S (NASDAQ:ASND) has a recorded annual revenue of $288.08 million. How much profit does Ascendis Pharma A/S generate each year? Ascendis Pharma A/S (NASDAQ:ASND) has a recorded net income of -$521.07 million. ASND has generated -$8.08 earnings per share over the last four quarters. What is Ascendis Pharma A/S's EPS forecast for next year? Ascendis Pharma A/S's earnings are expected to grow from ($7.11) per share to ($4.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies BNTX Earnings Date TEVA Earnings Date BGNE Earnings Date SMMT Earnings Date MRNA Earnings Date ITCI Earnings Date VTRS Earnings Date GMAB Earnings Date RDY Earnings Date SRPT Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Surges After Blockbuster Earnings: What's Next?Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip? This page (NASDAQ:ASND) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
